The novel anticoagulants: the surgeons' prospective.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 23218887.
- Also identified by DOI 10.1016/j.surg.2012.09.016.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Anticoagulants can complicate the approach to the management of patients undergoing operative interventions. We review new anticoagulants that have been introduced recently to the market or that are undergoing investigations for treatment of nonvalvular atrial fibrillation and venous thromboembolism prophylaxis: Dabigatran, rivaroxaban, apixiban, and edoxaban.
Medical subject headings
- Anticoagulants
- Surgical Procedures, Operative